Cours Burzynski Research Institute, Inc. Other OTC
Actions
BZYR
US1231591058
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 4,83 M 4,38 M |
---|---|---|---|---|---|
Résultat net 2022 | - 0 | Résultat net 2023 | - 0 | VE / CA 2022 | - |
Trésorerie nette 2022 | 3,38 k 3,07 k | Trésorerie nette 2023 | 934 846,84 | VE / CA 2023 | - |
PER 2022 |
-3
x | PER 2023 |
-3,68
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 18,99% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 81 | 01/01/84 | |
Director of Finance/CFO | 46 | 01/03/12 | |
Tomasz Janicki
PRN | Corporate Officer/Principal | 58 | 01/03/12 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 81 | 01/01/84 | |
Director/Board Member | 44 | 08/09/11 | |
Director/Board Member | 60 | 06/10/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,08% | 48,16 Md | |
-1,22% | 41,73 Md | |
+43,45% | 41,03 Md | |
-5,26% | 28,77 Md | |
+10,11% | 25,59 Md | |
-22,89% | 18,96 Md | |
+7,94% | 12,92 Md | |
+29,01% | 12,03 Md | |
-1,89% | 11,77 Md |